Neuronetics Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 165
Employees
  • Stock Symbol
  • STIM
Stock Symbol
  • Share Price
  • $4.12
  • (As of Friday Closing)

Neuronetics General Information

Description

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 3222 Phoenixville Pike
  • Malvern, PA 19355
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuronetics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.12 $4.31 $3.94 - $22.43 $114M 26.4M 398K -$1.13

Neuronetics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 93,309 196,815 35,605 263,601
Revenue 55,869 49,244 62,656 52,776
EBITDA (26,180) (25,890) (27,194) (22,427)
Net Income (27,214) (27,453) (29,044) (24,097)
Total Assets 143,068 78,657 100,168 117,022
Total Debt 38,542 38,335 34,326 30,395
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Neuronetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neuronetics‘s full profile, request access.

Request a free trial

Neuronetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Neuronetics‘s full profile, request access.

Request a free trial

Neuronetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products th
Therapeutic Devices
Malvern, PA
165 As of 2021
00000
000000 - 000 00000

0000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
00000000000 0000000
Maple Grove, MN
000 As of 0000
00000
00000000 00000

00000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
00000000000 0000000
Pompano Beach, FL
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuronetics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inspire Medical Systems Formerly VC-backed Maple Grove, MN 000 00000 00000000 00000
00000000 Venture Capital-Backed Pompano Beach, FL 000 00000 00000000000 00000
000000000 Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Baltimore, MD 00 000.00 00000000000 000.00
000000000 Corporation Jerusalem, Israel 000 000.00 00000000000 000.00
You’re viewing 5 of 11 competitors. Get the full list »

Neuronetics Patents

Neuronetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210228898-A1 Magnetic stimulation coils and ferromagnetic components for treatment and diagnostic procedures Pending 20-Feb-2018 00000000
US-11000693-B2 Magnetic stimulation coils and ferromagnetic components for treatment and diagnostic procedures Active 20-Feb-2018 00000000 00
US-20190255346-A1 Magnetic stimulation coils and ferromagnetic components for treatment and diagnostic procedures Granted 20-Feb-2018 00000000
US-10636520-B2 Head modeling for a therapeutic or diagnostic procedure Active 10-Feb-2014 000000000
US-20170372006-A1 Head modeling for a therapeutic or diagnostic procedure Granted 10-Feb-2014 G16H30/20

Neuronetics Executive Team (29)

Name Title Board Seat Contact Info
Keith Sullivan Chief Executive Officer & Board Member
Ravi Pillutla Director, Engineering Programs
John Pellechia Director, Quality Assurance
Neeraj Mainkar Director, Software Development
W. Macan JD General Counsel, Legal & Executive
You’re viewing 5 of 29 executive team members. Get the full list »

Neuronetics Board Members (26)

Name Representing Role Since
Brian Farley Neuronetics Chairman & Board Member 000 0000
Bruce Shook Self Board Member 000 0000
Glenn Muir MD Neuronetics Board Member 000 0000
John Bakewell Self Board Member 000 0000
Keith Sullivan Neuronetics Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 26 board members. Get the full list »

Neuronetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial